Categories
Archives
Receive Email Updates
-
-
-
Certified Licensing Professionals, Inc., 2021 
Disclaimer
This blog, Patents4Life, does not contain legal advice and is for informational purposes only. Its publication does not create an attorney-client relationship nor is it a solicitation for business. This is the personal blog of Warren Woessner and does not reflect the views of Schwegman Lundberg & Woessner, or any of its attorneys or staff. To the best of his ability, the Author provides current and accurate information at the time of each post, however, readers should check for current information and accuracy.
-
- About Me
Warren D. Woessner
Pages
Archives
Tag Archives: Warren Woessner
Supreme Court Denies Cert. in Sherley v. Sebelius
The pesky worry about a possible Supreme Court review of the ruling by the D.C. Court of Appeals affirming the Circuit Court’s dismissal of a challenge to the 2009 NIH Stem Cell Funding Guidelines – which permitted NIH funding of … Continue reading
Cold Spring Harbor Laboratory Conference on Patenting in the Life Sciences
I will be speaking at this conference in March, 2013. ************************* GENES & DIAGNOSTICS: A MYRIAD OF ISSUES IN BIOTECH IP March 10 – 13, 2013 REGISTRATION DEADLINE: March 1st http://meetings.cshl.edu/meetings/2013/patent13.shtml Cold Spring Harbor Laboratory is pleased to announce a … Continue reading
Posted in Conferences and Classes
Tagged biotechnology, biotechnology law, intellectual property, ip, Patent Law, Warren Woessner
1 Comment
Top Ten Biotech IP Stories of 2012
I admit, I am a sucker for lists, esp. Top Ten Lists, and a few days ago, sat through a half hour of “local news” wherein the anchors breathlessly related the Top Ten Rhode Island News Stories of 2012. Well, … Continue reading
Posted in Miscellaneous
Tagged AIA, Bilski, biotechnology news, David Kappos, Federal Circuit, Myriad, Patent Law, Prometheus v. Mayo, Supreme Court, Therasense, USPTO, Warren Woessner
2 Comments
In re Rosuvastatin Calcium Patent Litigation – Making “Therasense” out of Confusion
Recently, a divided three judge panel sorting out a multi-party Hatch-Waxman suit, ruled that the patentee, Shinonogi, had not committed inequitable conduct in obtaining the patent that was subsequently reissued so as to obtain narrow claims focused on Rosuvastatin, or … Continue reading
Posted in Inequitable Conduct/Rule 56, Reissue
Tagged AstraZenca, biotechnology, biotechnology law, biotechnology news, Crestor, Federal Circuit, Hatch-Waxman, inequitable conduct, intellectual property, ip, Patent Law, patents, reissue, Rosuvastatin, Shinonogi, Therasense, Warren Woessner
1 Comment